Insights

Global Market Presence Alfasigma operates in over 100 markets across Europe, the Americas, Asia, and Africa, presenting extensive opportunities for regional partnerships, distribution expansion, and tailored product offerings to diverse healthcare systems.

Strategic R&D Expansion With research and development centers in Italy and a strong focus on innovative therapies such as Lynavoy and linerixibat, there is significant potential to collaborate on new drug development projects and leverage cutting-edge biotech advancements.

Recent Licensing Success Alfasigma's recent licensing agreements with GSK for development and marketing rights indicate openness to strategic partnerships and licensing deals that can accelerate product commercialization and market penetration worldwide.

Therapeutic Focus Areas Specializing in Gastroenterology, Vascular, and Rheumatology, Alfasigma offers multiple opportunities to supply raw materials, APIs, and formulation services tailored to its core therapeutic segments and emerging niche markets.

Growing Financial Capacity With revenues between one to ten billion dollars and recent substantial investments, Alfasigma has the financial strength to acquire new assets, invest in joint ventures, and expand its product portfolio in high-growth pharmaceutical sectors.

Alfasigma Tech Stack

Alfasigma uses 8 technology products and services including Automation Anywhere, UiPath, WordPress, and more. Explore Alfasigma's tech stack below.

  • Automation Anywhere
    Business Process Management
  • UiPath
    Business Process Management
  • WordPress
    Content Management System
  • Oracle
    Enterprise
  • Google Fonts API
    Font Scripts
  • jQuery UI
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • WPForms
    Web Platform Extensions

Media & News

Alfasigma's Email Address Formats

Alfasigma uses at least 1 format(s):
Alfasigma Email FormatsExamplePercentage
First.Last@alfasigma.comJohn.Doe@alfasigma.com
88%
FLast@alfasigma.comJDoe@alfasigma.com
8%
First.MiddleLast@alfasigma.comJohn.MichaelDoe@alfasigma.com
2%
Last.First@alfasigma.comDoe.John@alfasigma.com
2%

Frequently Asked Questions

Where is Alfasigma's headquarters located?

Minus sign iconPlus sign icon
Alfasigma's main headquarters is located at N.5 Viaduct Ragazzi Del '99 Bologna, Emilia-romagna 40133 Italy. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Alfasigma's official website and social media links?

Minus sign iconPlus sign icon
Alfasigma's official website is alfasigma.com and has social profiles on LinkedInCrunchbase.

What is Alfasigma's SIC code NAICS code?

Minus sign iconPlus sign icon
Alfasigma's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Alfasigma have currently?

Minus sign iconPlus sign icon
As of March 2026, Alfasigma has approximately 2.7K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: F. B.Cfo Italy: R. R.Cmo Technical Unit: A. C.. Explore Alfasigma's employee directory with LeadIQ.

What industry does Alfasigma belong to?

Minus sign iconPlus sign icon
Alfasigma operates in the Pharmaceutical Manufacturing industry.

What technology does Alfasigma use?

Minus sign iconPlus sign icon
Alfasigma's tech stack includes Automation AnywhereUiPathWordPressOracleGoogle Fonts APIjQuery UIGoogle Tag ManagerWPForms.

What is Alfasigma's email format?

Minus sign iconPlus sign icon
Alfasigma's email format typically follows the pattern of First.Last@alfasigma.com. Find more Alfasigma email formats with LeadIQ.

How much funding has Alfasigma raised to date?

Minus sign iconPlus sign icon
As of March 2026, Alfasigma has raised $176M in funding. The last funding round occurred on Jul 08, 2025 for $176M.

Alfasigma

Pharmaceutical ManufacturingEmilia-romagna, Italy1001-5000 Employees

Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan). 

The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo).

Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers. 

It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.

Read here our social media netiquette: https://it.alfasigma.com/informative-privacy/netiquettesocialnetwork/

Section iconCompany Overview

Headquarters
N.5 Viaduct Ragazzi Del '99 Bologna, Emilia-romagna 40133 Italy
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $176M

    Alfasigma has raised a total of $176M of funding over 1 rounds. Their latest funding round was raised on Jul 08, 2025 in the amount of $176M.

  • $1B$10B

    Alfasigma's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $176M

    Alfasigma has raised a total of $176M of funding over 1 rounds. Their latest funding round was raised on Jul 08, 2025 in the amount of $176M.

  • $1B$10B

    Alfasigma's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.